We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Solvent May Prevent Stroke from Brain Aneurysm

By HospiMedica staff writers
Posted on 11 Nov 2003
A clinical trial is testing the ability of a new spongy polymer to repair brain aneurysms and thereby prevent rupture and hemorrhagic stroke.

The trial involves 120 patients with brain aneurysms who will undergo a new procedure utilizing a solvent called dimethyl sulfoxide, derived from lignin, a compound found in woody plants. More...
Doctors will use a catheter from the groin to a carotid artery in the brain to locate the aneurysm and inject the solvent into the sac. When the solvent comes in contact with blood or body fluids, it is designed to rapidly diffuse from the liquid, transforming it into a spongy, polymer mass that displaces the blood in the sac and seals off the defect.

Initially, two patients underwent the procedure at the Oregon Health & Science University (OHSU, Portland, USA) who were at risk of rupture from a brain aneurysm. Both were able to go home the next day, with no complications. The solvent method, called Onyx Liquid Embolic System, was developed by Micro Therapeutics, Inc. (Irvine, CA, USA; www.microtherapeutics.com), as an improvement over surgical clipping or coiling. Coiling patients have a 20% aneurysm recurrence rate.

"Coils can stick out, and sometimes you can't get the coil where you need it,” said Wayne M. Clark, M.D., professor of neurology at OHSU's School of Medicine. "Whether it's better than coiling, that's what the study is evaluating. It certainly looks very promising.”





Related Links:
Oregon H&S U.
Micro Therapeutics

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.